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Marked increase in leptin concentration in spent peritoneal
dialysate has been reported following continuous
ambulatory peritoneal dialysis treatment. The present study
was designed to determine whether functional leptin
receptor is expressed by human peritoneal mesothelial cells
and if so, the possible implication in dialysis. Expression of
leptin receptors in cultured mesothelial cells and omental
tissue was examined. The effect of leptin on the production
of transforming growth factor-b (TGF-b) by mesothelial cells
in the presence or absence of high glucose was determined
using in vitro culture model of human peritoneal mesothelial
cells and adipocytes. The signaling mechanism involved in
leptin-induced TGF-b synthesis by mesothelial cells was
studied. Both mRNA and protein of the full-length leptin
receptor are constitutively expressed in mesothelial cells. The
leptin receptor expression in mesothelial cells was
upregulated by glucose but not leptin. In adipocytes, glucose
increased the mRNA expression and synthesis of leptin. The
Janus kinase-signal transducers and activation (JAK-STAT)
signal transduction pathway in mesothelial cells was
activated by either exogenous or adipocytes-derived leptin.
Exogenous leptin induced the release of TGF-b by
mesothelial cells. The TGF-b synthesis induced by leptin was
amplified by glucose through increased leptin receptor
expression. Our novel findings reveal that functional leptin
receptor is present on human peritoneal mesothelial cells.
The leptin-induced TGF-b synthesis in mesothelial cells is
associated with the expression of leptin receptor and the
activation of the JAK-STAT signal transduction pathway.
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Continuous ambulatory peritoneal dialysis (CAPD) is an
important treatment modality of the renal replacement
therapy. Unfortunately, the peritoneal membrane frequently
exhibits structural and functional changes following long-
term dialysis.1 During CAPD, peritoneal cells are repeatedly
exposed to a nonphysiological hypertonic environment that
may lead to peritoneal fibrosis and, ultimately, ultrafiltration
failure.2
Human peritoneal adipocytes (HPAC) are ubiquitously
found in peritoneal tissues. There is now compelling evidence
suggesting adipocytes can mediate various physiologic
processes through secretion of adipokines, including leptin,
adiponectin, resistin, tumour necrosis factor-a, interleukin-6,
transforming growth factor-b (TGF-b), tissue factors, and
other growth factors.3,4 Adipocytes also express receptors for
leptin, insulin growth factor-1, tumour necrosis factor-a,
interleukin-6, TGF-b that orchestrate a network of autocrine,
paracrine, and endocrine signals.4 In parietal peritoneum,
adipocytes lie deep underneath the mesothelium. During the
fluid dwell in CAPD, solutes in peritoneal dialysis fluid
(PDF) are transported by passive diffusion through the
peritoneal barrier and come into contact with the adipocytes.
In the omentum, adipocytes are in close contact with
mesothelial cells. Ultrastructural study reveals that a portion
of adipocytes are protruded from the mesothelial surface,
suggesting that omental adipocytes may be directly exposed
to dialysate.5 In addition, dialysate can also reach the parietal
adipose tissue when there is junctional damage or denuda-
tion of the mesothelial monolayer. It is therefore logical to
postulate that under repeated exposure to PDF and the
continuous changes of the physiologic milieu of the
peritoneal cavity during CAPD, peritoneal adipocytes will
inevitably be ‘activated’. Yet, study on any impact of CAPD
on peritoneal adipocytes is scarce.
Leptin, an adipocytes-derived 16-kDa hormone, exerts
many biological effects through leptin receptor.4,6 Leptin
receptors belong to the class I cytokine family with six spliced
isoforms (Ob-Ra to Ob-Rf).4 Only the full-length isoform,
Ob-Rb, contains the intracellular motifs essential for the
Janus kinase-signal transducers and activation (JAK-STAT)
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signal transduction pathway.4,7 Accumulating evidence for
systemic effects of leptin on specific tissues and metabolic
pathways indicates that leptin operates both directly
and indirectly to orchestrate complex pathophysiological
processes.6,8 Leptin is cleared principally by the kidney
and the serum leptin concentration is increased in patients
with chronic renal failure or undergoing dialysis.9 Marked
increase in leptin concentration from serum and spent
dialysate has been reported following CAPD treatment.10
Leptin in peritoneal dialysate is derived not only from plasma
but also locally from peritoneal adipose tissue. In vitro
experiments using adipocyte cell line 3T3-L1 showed
glucose-based PDFs induce a higher leptin secretion.11 In
the present study, we determine whether functional leptin
receptors are expressed by human peritoneal mesothelial
cells (HPMC) and if so, whether these mesothelial leptin
receptors could be triggered by leptin to modulate local
TGF-b production.
RESULTS
Culture of HPMC and HPAC
Figure 1 shows the cultured cells used in our study. HPMC
showed typical cobblestone appearance at confluence (Figure
1a). For in vitro experiments, adipocyte differentiation was
initiated by culturing preadipocytes (Figure 1b) in adipo-
genic medium. After 15 days of differentiation, 90% of cells
are positively stained with Oil Red O for neutral lipid
accumulation (Figure 1C).
Expression of Ob-Rb in omental tissue and cultured HPMC
Expression of the Ob-Rb mRNA (Figure 2a) and protein
(Figure 2b) was demonstrated in three different lines of
HPMC. Expression of Ob-Rb was confirmed for peripheral
blood mononuclear cells and HepG2 cells, which served as
positive control for the reverse transcriptase-polymerase
chain reaction (RT-PCR).12,13 Expression of Ob-Rb was
detected on cell surface of peritoneal mesothelial cells and
adipocytes in omentum (Figure 3). However, HPMC do not
produce leptin either constitutively or after incubation with
glucose (data not shown).
Glucose upregulates Ob-Rb expression by HPMC
Figure 4 shows the time course of Ob-Rb expression
by HPMC cultured with glucose or mannitol. Expression of
Ob-Rb mRNA (Figure 4a) or protein (Figure 4b) was
significantly increased in HPMC by incubation with glucose
but not with mannitol after 12 h and plateaued at 72 h
(Po0.005). Similarly, glucose but not mannitol upregulated
Ob-Rb mRNA (Figure 5a) and protein expression (Figure 5b)
in HPMC in a dose-dependent manner.
Glucose upregulates leptin mRNA and protein expression
by HPAC
Significant increase in mRNA expression of leptin was
detected in HPAC after exposed to 40 mM glucose for
12–48 h (Po0.005) (Figure 6a). Then, the leptin expression
fell at 72 h and the level remained not different from the
baseline value. Glucose significantly increased leptin release
from HPAC after exposure for 48 h (Po0.005) (Figure 6b).
Glucose at concentration of 20 mM or greater significantly
increased the leptin mRNA expression (Figure 7a) and
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Figure 1 | Culture of peritoneal mesothelial cells and adipocytes.
Micrographs showing (a) human omental mesothelial cells,
(b) preadipocytes, and (c) differentiated adipocytes in culture.
The differentiated adipocytes (HPAC) were positively stained with
Oil Red O (original magnification  100).
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Figure 2 | Expression of Ob-Rb in mesothelial cells. Expression of
(a) full-length Ob-Rb mRNA and (b) protein in cultured human
mesothelial cells. Lanes 1–3 were HPMC cell lines. The liver cell line
HepG2 (lane 4), human peripheral mononuclear cells (lane 5), and
omental tissue (lane 6) were served as a positive control for Ob-Rb
expression.
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Figure 3 | Immunostaining of Ob-Rb in omental tissue. (b and c)
Representative immunohistochemical staining of Ob-Rb in human
omental tissue. Omental mesothelial cells (arrow head) and
adipocytes (arrow) showed strong immunoreactivity for Ob-Rb
(brown). (a) No staining was observed for isotypic control (original
magnification (a and b)  200, (c)  1000).
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protein release (Figure 7b) (Po0.005 for both). Similar
upregulation was not observed with mannitol. Expression of
Ob-Rb HPAC was not affected by glucose (data not shown).
Leptin did not alter the expression of Ob-Rb but increased
the TGF-b release by HPMC
Incubation with increasing dose of leptin (5–40 ng/ml) failed
to upregulate the expression of OB-Rb in HPMC (Figure 8a).
However, leptin at concentration of 10 ng/ml or greater
significantly increased the TGF-b mRNA expression and
protein release by HPMC (Po0.005) (Figure 8b).
Activation of JAK-STAT signal transduction pathway in HPMC
by leptin
Figure 9 shows the detection of phospho-JAK2 and phospho-
STAT3 of the JAK-STAT pathway, phospho-pan-protein
kinase (PKC) or c-fos in lysate from HPMC following
incubation with medium containing glucose (5.6–80 mM),
medium containing leptin (0–40 ng/ml), control-HPAC, or
glucose-HPAC medium. Increasing concentration of glucose
activated the PKC but not the JAK-STAT pathway in a
stepwise fashion. In contrast, leptin activated the JAK2,
STAT3, and c-fos but not PKC in HPMC. Activation of the
JAK-STAT, c-fos, and PKC pathways were detected in HPMC
incubated with glucose-HPAC medium but not with control-
HPAC medium.
Roles of PKC and JAK-STAT signaling pathways
To study the roles of PKC and JAK-STAT signaling pathways
in TGF-b release from HPMC induced by glucose or/and
leptin, HPMC was cultured with medium containing 5.6 or
40 mM glucose, 40 mM glucose plus 20 ng/ml leptin, and
glucose-HPAC medium in the absence or presence of
neutralizing antibody to leptin receptor, inhibitor to JAK2
(AG490; 10 mM), or/and PKC (calphostin; 100 nM). Leptin
upregulated TGF-b release by HPMC (Figure 10). Addition
of glucose further amplified this TGF-b release. There was
synergistic increase (960% of basal value) in TGF-b synthesis
by HPMC exposed to 40 mM glucose plus 20 ng/ml leptin.
AG490, anti-leptin receptor or calphostin alone only reduced
TGF-b release to 575, 637, or 340% of that of the basal level.
The TGF-b release in HPMC induced by simultaneous
exposure to glucose and leptin was completely abolished only
with the presence of both AG490 and calphostin. The
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Figure 4 | Time-dependent upregulation of Ob-Rb expression
in HPMC by glucose. Time–response curve for (a) Ob-Rb mRNA and
(b) protein expression in HPMC upon exposure to glucose. Treatment
with glucose (40 mM; dark bar) but not mannitol (40 mM; white bar)
led to a time-dependent upregulation in Ob-Rb mRNA and protein
expression in HPMC. Measurement of Ob-Rb mRNA at time intervals
12, 24, 48, and 72 h; or Ob-Rb protein at time intervals 24, 48, and
72 h differed significantly from values at time zero. Data are
mean7s.d. of four individual experiments. *Po0.005.
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Figure 5 | Dose-dependent upregulation of Ob-Rb expression
in HPMC by glucose. Dose–response curve for (a) Ob-Rb mRNA and
(b) protein expression in HPMC upon exposure to glucose for 24
(mRNA) or 48 h (protein). Treatment with increasing concentration of
glucose (dark bar) but not mannitol (white bar) led to a dose-
dependent upregulation in Ob-Rb mRNA and protein expression in
HPMC. Measurement of Ob-Rb mRNA at high concentrations of
glucose (20, 40, and 80 mM) differed significantly from the baseline
value at 5 mM. Data are mean7s.d. of four individual experiments.
*Po0.005.
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concentrations of glucose and leptin in the conditioned
medium were 3672 mM and 9.271.4 ng/ml, respectively.
Glucose-HPAC medium significantly increased TGF-b synth-
esis by HPMC (803% of basal level). AG490, calphostin, and
antileptin receptor reduced 39.7, 86.96, and 33.1% of the
increased TGF-b level, respectively.
DISCUSSION
To the best of our knowledge, this is the first study showing
that HPMC express a functional full-length leptin receptor,
the Ob-Rb. We have demonstrated that Ob-Rb is constitu-
tively expressed in cultured HPMC and human omental
tissue by RT-PCR, immunoblotting, and immunohistochem-
ical staining. The expression of Ob-Rb in HPMC was
upregulated following exposure to glucose. The synthesis of
leptin by HPAC is upregulated by glucose but not by
equimolar mannitol. These data are in keeping with the
recent finding that glucose-based PDF induces a higher leptin
secretion by murine adipocyte cell line 3T3-L1 compared
with dialysate with lower glucose concentration or without
glucose.11
High glucose content in the dialysate is a major factor
causing the structural and functional abnormalities in
peritoneal cells during CAPD.14,15 Decreased expression of
intercellular junctional proteins ZO-1 and b-catenin is
observed in HPMC cultured with glucose.16 Glucose
upregulates TGF-b and fibronectin synthesis by HPMC.17,18
TGF-b is involved in various pathophysiological events in
peritoneal biology.19 Overexpressed TGF-b in murine
mesothelial cells results in peritoneal membrane fibrosis
and loss of ultrafiltration.20 In an animal model of peritoneal
dialysis, inhibition of TGF-b function and production
reduces peritoneal fibrosis.21 Glucose-induced TGF-b up-
regulation in kidney mesangial cells and HPMC is mediated
by PKC.18,22 High glucose induces de novo synthesis of
diacylglycerol and activate PKC in HPMC.23 Activation of
PKC leads to transcription of c-fos and c-jun early response
gene.24 The c-fos and c-jun proteins can form dimeric
complexes with each other that bind to the activator protein-
1 (AP-1) consensus sequence to activate the promoter
activity.25 It has been shown that the AP-1 box B binding
sites on the TGF-b promoter mediate the high glucose
response in mesangial cells.26 High glucose increases the
TGF-b promoter activity by enhancing the expression of
c-fos, and hence its binding to AP-1. The involvement of c-fos
in regulating the TGF-b promoter activity is well demons-
trated by the observation that heparin prevents TGF-b
activation induced by glucose through reducing the c-fos
expression, and thereby preventing the formation of activated
AP-1 complexes.27
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Figure 6 | Time-dependent upregulation of leptin expression
in HPAC by glucose. Time–response curve for (a) leptin mRNA and
(b) protein expression in HPAC upon exposure to glucose. Treatment
with glucose (40 mM; dark bar) but not mannitol (40 mM; white bar)
led to a time-dependent upregulation in leptin gene and protein
expression in HPAC. Measurement of leptin mRNA at time intervals
12 h, 24, and 48 h differed significantly from values at time zero.
Significance was not observed at 72 h when compared with baseline
values. Measurement of leptin protein at 48 and 72 h differed
significantly from value at time zero. Data are mean7s.d. of four
individual experiments. *Po0.005.
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Figure 7 | Dose-dependent upregulation of leptin expression
in HPAC by glucose. Dose–response curve for (a) leptin mRNA and
(b) protein expression in HPAC upon exposure to glucose for 24
(mRNA) or 48 h (protein). Treatment with increasing concentration of
glucose (dark bar) but not mannitol (white bar) led to a dose-
dependent upregulation in leptin gene and leptin release in HPAC.
Measurement of leptin mRNA at high-dose concentrations of glucose
(20, 40, and 80 mM) differed significantly from baseline value at 5 mM.
Data are mean7s.d. of four individual experiments. *Po0.005.
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In the present study, we have demonstrated that leptin
upregulates the gene expression and protein release of TGF-b
in HPMC. HPMC do not produce leptin constitutively or
after incubation with high glucose, and there could be a
paracrine effect of HPAC-derived leptin on HPMC expres-
sion of TGF-b. It had been shown that leptin enhanced
aromatase expression in the breast cancer cell line via AP-1.28
We next examined whether leptin-induced TGF-b synthesis
in HPMC is mediated through signal pathways involving
PKC and AP-1. Our data showed that PKC is not activated by
leptin and neither the leptin-induced TGF-b synthesis is
abolished by a PKC inhibitor. Hence, unlike TGF-b synthesis
in HPMC induced by high glucose, TGF-b synthesis in
HPMC induced by leptin is independent of the PKC pathway.
Leptin triggers Ob-Rb signaling through the JAK-STAT signal
transduction pathway.7 In vascular smooth muscle cells, high
glucose enhances the angiotensin II-induced cell proliferation
through the JAK-STAT pathway.29 In glomerular mesangial
cells, inhibition of the JAK-STAT pathway prevents the
glucose-induced TGF-b and fibronectin synthesis.30 Our
immunoblotting data have revealed that leptin, but not
glucose, is able to activate JAK2 and STAT3. Furthermore, the
TGF-b synthesis in HPMC induced by leptin was abolished
by a JAK2 specific inhibitor, AG490. Taken these observations
together, TGF-b synthesis in HPMC induced by leptin is
triggered by Ob-Rb signaling involving the JAK-STAT
pathway. It has been shown that activated STAT3 binds to
c-fos promoter and upregulates c-fos transcription.31 It is
likely that the downstream event in leptin-induced TGF-b
synthesis by HPMC is similar to the mechanism of high
glucose-mediated TGF-b synthesis, which involves an
increased c-fos expression and TGF-b promoter activity.
Our data show that in the presence of 40 mM glucose or
20 ng/ml leptin, there was 583 or 349% increase in TGF-b
synthesis by HPMC. However, glucose (40 mM) amplified the
leptin-induced TGF-b synthesis by HPMC (1113% (gluco-
seþ leptin) versus 932% (glucose or leptin
583þ 349¼ 932%). This amplification of TGF-b synthesis
is likely to be due to the increased expression of Ob-Rb in
HPMC by high glucose. Indeed, our inhibition studies show
that TGF-b synthesis by HPMC in the presence of both
glucose and leptin was abolished only by using both PKC and
JAK2 inhibitors but not with either one alone. Based on our
present data, a hypothetical model of leptin-induced TGF-b
synthesis in HPMC is proposed (Figure 11). TGF-b synthesis
by HPMC is upregulated by glucose through PKC-dependent
mechanisms. HPMC exposed to high glucose will induce
PKC activation. PKC will then upregulate the transcription
factors c-fos and c-jun, which form complexes with the AP-1
a
b
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Figure 8 | Effect of exogenous leptin on Ob-Rb expression and
TGF-b release by HPMC. (a) Expression of Ob-Rb mRNA (white bar)
or protein (dark bar) was not altered in HPMC cultured with different
concentration of leptin for 24 h (mRNA) or for 48 h (protein). (b)
Release of TGF-b in HPMC cultured with increasing doses of leptin for
48 h. The expression of TGF-b mRNA (white bar) was significantly
increased in HPMC incubated with leptin at 20 and 40 ng/ml. The
release of TGF-b (dark bar) was up-regulated in HPMC incubated with
leptin at 10, 20, and 40 ng/ml. Data are mean7s.d. of four individual
experiments. *Po0.005.
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Figure 9 | Detection of different phospho-specific signals in
HPMC lysate following incubation with glucose, leptin,
glucose-HPAC conditioned medium, or control-HPAC
conditioned medium. (a) Activation of the PKC signal transduction
pathway was detected in HPMC incubated with glucose or
glucose-HPAC medium but not with leptin or control-HPAC medium.
(b) Activation of the JAK2, STAT3, and c-fos signal transduction
pathways was detected in HPMC incubated with leptin or
glucose-HPAC conditioned medium but not with glucose or
control-HPAC conditioned medium.
2082 Kidney International (2006) 69, 2078–2086
o r i g i n a l a r t i c l e JCK Leung et al.: Leptin induces TGF-b synthesis by mesothelial cell
binding site and enhance the binding of AP-1 proteins to the
AP-1 box B on the TGF-b promoter. Although leptin cannot
activate the PKC pathway directly, it does activate the JAK2
and STAT3 through the functional Ob-Rb expressed on
HPMC. Activated STAT3 accumulates on the c-fos promoter
and increases c-fos transcription. Since high glucose also
upregulates the expression of Ob-Rb on HPMC, in the
presence of leptin and high glucose, upregulation of TGF-b
synthesis by leptin will further be amplified through Ob-Rb
and the JAK-STAT3-dependent pathway. Pathways other than
JAK-STAT could also be involved in mediating leptin’s action.
In peripheral blood mononuclear cells, leptin activates the
MAPK and phosphatidyl-inositol 30-kinase pathways, and is
implicated in regulating cell growth and glucose metabo-
lism.32 It has been shown that leptin directly suppressed
peroxisome proliferator-activated receptor-g expression in
adipocytes. In kidney mesangial and tubular cells, peroxi-
some proliferator-activated receptor-g agonist attenuated
high glucose-induced TGF-b release. It is not known whether
HPMC expressed peroxisome proliferator-activated receptor-
g and if it is present, the effect of peroxisome proliferator-
activated receptor-g expression on leptin-induced TGF-b
release by HPMC. Further examination of these additional
pathways in modulating the leptin-induced TGF-b release by
HPMC is warranted.
Leptin is elevated during acute infection, in response to
proinflammatory cytokines including interleukin-1 and
tumour necrosis factor-a.9 In the kidney, leptin stimulates
cell proliferation, collagen IV and TGF-b synthesis in
glomerular endothelial cells,33 and increases the glucose
transport, upregulates the expression of TGF-b type II
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Figure 10 | Blocking study of TGF-b release by HPMC. Concentration of TGF-b in culture supernatant from HPMC incubated with
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in the absence (white bar) presence of anti-leptin receptor antibody (crossed bar; last bar in each group; 50mg/ml), inhibitor to JAK2
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Figure 11 | Hypothetical model of leptin-induced TGF-b synthesis
in HPMC. HPMC exposed to high glucose will induce PKC activation.
PKC will then upregulate the transcription of early response genes,
c-fos or/and c-jun, which form complexes with the AP-1 binding site
and enhance the binding of AP-1 proteins to the AP-1 box B on the
TGF-b promoter. TGF-b synthesis is upregualted by high glucose
through this PKC-dependent mechanism. Although leptin cannot
activate the PKC pathway directly, it does activate the JAK2 and
STAT3 through the functional Ob-Rb expressed on HPMC. Activated
STAT3 accumulates on the c-fos promotor and provides a boost to
c-fos transcription. High glucose upregulates the expression of
Ob-Rb by HPMC as well the PKC-dependent TGF-b synthesis. In the
presence of leptin and increased Ob-Rb expression by HPMC
stimulated with high glucose, upregulation of TGF-b synthesis will be
further amplified through the JAK-STAT pathway.
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receptor and collagen I synthesis through phosphatidylino-
sitol-3-kinase related pathway in glomerular mesangial
cells.34 These data suggest that leptin triggers a paracrine
interaction between glomerular endothelial and mesangial
cells through upregulation of TGF-b in glomerular endothe-
lial cells together with increased TGF-b receptor expression in
mesangial cells. Whether such paracrine interaction is
operating between peritoneal adipocytes and HPMC remains
to be explored. Here, we present the first evidence that
adipocyte-derived leptin can exert paracrine effect on HPMC
through upregulation of Ob-Rb receptor and activation of
the JAK-STAT pathway.
It must be emphasized that data obtained from cultured
cells model may not exactly reflect in vivo situation. During
CAPD, mesothelial cells and adipocytes are exposed to un-
physiological low pH and high glucose PDF. PDF also
contains toxic substances including glucose degradation
products. All these factors work together with the cytokines
and adipokines networks from peritoneal cells in affecting the
TGF-b synthesis by mesothelial cells. For the present study,
culture model was employed to allow examination of specific
variables (high glucose, leptin and Ob-Rb expression), and
this will give a preliminary idea of what could be happened
in vivo during peritoneal dialysis. It is of important to
examine the in vivo expression of Ob-Rb and related
signaling pathway in patients before and under long-term
CAPD and future investigation is warranted.
In conclusion, our study provides novel data that leptin
can activate the JAK-STAT signal transduction pathway and
increase the synthesis of TGF-b by HPMC through triggering
the functional Ob-Rb receptor. In the presence of high
glucose, leptin-induced TGF-b synthesis by HPMC is
enhanced. Our results implicate that adipocyte-derived leptin
may contribute to the peritoneal dysfunction in dialysis
through a paracrine effect on mesothelial TGF-b synthesis.
MATERIALS AND METHODS
Materials
All reagents for tissue culture were obtained from Invitogen Co
(Carlsbad, CA, USA). Monoclonal anti-Ob-Rb, neutralizing
anti-leptin receptor antibody and leptin protein were obtained
from R&D System (Minneapolis, MN, USA). Monoclonal mouse
anti-actin was obtained from Lab Vision (Fremont, CA, USA).
Secondary antibodies for immunohistochemical staining and
immunoblotting were obtained from Dako (Carpinteria, CA,
USA). Antibodies to phospho-JAK2, phospho-STAT3, pan-PKC
and c-fos were obtained from Cell Signaling Technology (Beverly,
MA, USA). All other chemicals were obtained from Sigma (St Louis,
MO, USA).
Culture of HPMC
The study was conducted in accordance with the Declaration of
Helsinki Principles and was approved by the institutional ethics
committee for studies in human. Full informed consent for
removing small pieces of omental tissue for experimental studies
was obtained from patients. Omentum tissue was obtained from five
nonuraemic, nondiabetic patients (male, age 45–55) under elective
abdominal surgery for early gastric cancer. The patients have not
been previously exposed to peritoneal dialysis treatment, and were
clinically not inflamed. The omental samples collected were further
examined histologically to be free of other pathological conditions
including inflammation, metastasis, and endometriosis. Mesothelial
cells were isolated and characterized using procedures described
previously.35 Once monolayer of HPMC reached confluence
(HPMC of second or third passage were used in all experiments),
the cells were growth-arrested with serum-free medium for 24 h
prior to experiments. Under these conditions, the HPMC remained
in a nonproliferative viable condition.
Culture of peritoneal adipocytes
Omental adipocyte precursors from the stromal vascular fraction
were isolated by collagenase digestion.36 For in vitro experiments,
adipocytes were differentiated by culturing stromal vascular fraction
in adipogenic medium (Dulbecco’s modified Eagle’s medium/Ham’s
F12 media supplemented with 10 mg/ml transferrin, 100mM ascorbic
acid 2-sodium, 0.85mM insulin, 20 nM sodium selenite, 0.2 nM
triiodothyronine, 1 mM dexamethasone, 100 mM isobutyl-methyl-
xanthine, and 1 mM rosiglitazone). The medium was changed 3 days
later (dexamethasone and isobutyl-methylxanthine were omitted).
After 15 days of differentiation, 90% of cells are positively stained
with Oil Red O for neutral lipid accumulation. These differentiated
adipocytes were cultured in serum-free M199 medium for 24 h prior
to experiment.
Immunohistochemical staining
The expression of Ob-Rb in 4 mm-thicked omental paraffin sections
was determined by immunohistochemical staining using mouse
anti-Ob-Rb (0.5 mg/ml). The bound antibody was visualised as
brown colour using the Dako Envision Plus System (Dako).
Preparation of M199 medium containing mannitol
The basal glucose concentration in M199 medium is 5.6 mM,
for all experiment involving the use of mannitol as osmolarity
control, the concentration of mannitol added to the M199
medium are 0, 4.4, 14.4, 34.4, and 74.4 mM (plus 5.6 mM glucose
in the M199 medium) to generate different sugar concentration (5.6,
10, 20, 40, and 80 mM). For simplicity, these ‘5.6 mM glucose
þmannitol’ medium are named as 5.6, 10, 20, 40, or 80 mM
mannitol.
Preparation of conditioned medium from HPAC exposed to
glucose
HPAC were cultured with M199 medium containing glucose
(40 mM) for 48 h. The conditioned medium (glucose-HPAC
medium) was stored at 701C until used. The conditioned media
were centrifuged for 10 min at 2000 g before experiment. Condi-
tioned medium from HPAC cultured with 5.6 mM basal glucose level
(control-HPAC medium) was used as control.
Expression of Ob-Rb by HPMC exposed to glucose
For time–response experiment, HPMC (0.5 106 cells) were
exposed to 40 mM glucose or mannitol for 0, 6, 12, 24, 48, and
72 h. For dose–response experiment, HPMC were cultured with 5.6,
10, 20, 40, and 80 mM glucose or mannitol for 24 h (mRNA
expression) or 48 h (protein release). At any particular time point or
at the end of experiment, cells were harvested for total RNA or lysate
preparation for determination of expression of Ob-Rb using RT-
PCR or immunoblotting.
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Expression of leptin mRNA and protein by HPAC exposed to
glucose
For time–response experiment, HPAC (1 105 cells) were exposed
to 40 mM glucose or mannitol for 0, 6, 12, 24, 48, and 72 h. For
dose–response experiment, HPAC were cultured with 5.6, 10, 20, 40,
and 80 mM glucose or mannitol for 24 h (mRNA expression) or 48 h
(protein release). At any particular time point or at the end of
experiment, culture supernatants were collected for assay of leptin
by ELISA and cells were harvested for total RNA preparation.
Effect of leptin on the expression of Ob-Rb and synthesis of
TGF-b by HPMC
HPMC were exposed to 0, 5, 10, 20, and 40 ng/ml leptin for 24 h
(mRNA) or 48 h (protein). At the end of experiment, culture
supernatants were collected for assay of TGF-b by an ELISA and cells
were harvested for total RNA or cell lysate preparations. Ob-Rb or
TGF-b mRNA expression was determined by RT-PCR and Ob-Rb
protein expression was assayed by immunoblotting.
Activation of JAK-STAT and PKC signal transduction pathways
HPMC/HPAC were exposed to glucose (5.6–80 mm), leptin
(0–40 ng/ml), glucose-HPAC medium, or control medium for
30 min. The expression of phospho-JAK2, phospho-STAT3, and
phospho-PKC by HPMC was determined using immunoblotting. In
another sets of experiment, HPMC were cultured with M199
containing (i) 5.6 mM glucose, (ii) 40 mM glucose, (iii) 40 mM
glucose plus 20 ng/ml leptin, or (iv) glucose-HPAC medium in the
absence or presence of inhibitor to JAK2 (AG490; 10 mM) and/or
PKC (calphostin; 100 nM); or anti-leptin receptor antibody for 48 h
(the inhibitors or antibody were added 1 h before experiment
started). At the end of experiment, the TGF-b concentration in the
culture supernatant was assayed by ELISA.
Gene expression study
Cells were harvested and total cellular RT-PCR was performed as
previously described.37 The hepatocellular line HepG2 was obtained
from American Type Culture Collection (ATCC; Rockville, MD, USA)
and the human peripheral blood mononuclear cells were isolated
from healthy donors by Ficoll gradient separation as previously
described.38 The RNAs obtained from these cells were used as a
positive control for Ob-Rb expression. Primers for Ob-Rb, leptin,
TGF-b, and glyceraldehyde-3-phosphate dehydrogenase were de-
signed from GeneBank sequences (Ob-Rb U43168; leptin D49487;
TGF-b X02812 and glyceraldehyde-3-phosphate dehydrogenase
AF261085). The sequences of primers (sense and antisense) are: (i)
Ob-Rb, 50-TCACCCAGTGATTACAAGCT and 50-CTGGAGAACTCT
GATGTCCG; (ii) leptin, 50-GCTGTGCCCATCCAAAAAGT and 50-
ACTGCCAGTGTCTGGTCCAT; (iii) TGF-b, 50-GCCCTGGACAC
CAACTATTGCT and 50-AGGCTCCAAATGTAGGGGCAGG; (iv)
glyceraldehyde-3-phosphate dehydrogenase, 50-TGAAGGTCGGAGT
CAACGGATTTGGT and 50-CATGTGGGCCATGAGGTCCACCAC.
The PCR products for Ob-Rb, leptin, or TGF-b (1071, 179, or
161 bp) and control (glyuraldehyde-3 phosphate dehydrogenase;
452 bp) were mixed and separated by 1.5% wt/vol agarose gels. The
results was analysed using the Gel Doc 1000 Gel Documentation
System (Bio-Rad Laboratories Ltd., Hercules, CA, USA).
Immunoblotting
Cells were lysed with buffer containing protease inhibitor cocktails
(Sigma). The protein concentrations in cell extracts were measured
by a modified Lowry method (DC protein assay kit, BioRad). A total
of 10 mg of total protein from the extract was electrophoresed and
then transferred onto a polyvinylidine difluoride membrane. The
membrane was incubated with mouse anti-Ob-Rb antibody
(1:1000), anti-actin antibody (1:1000); rabbit anti-phospho JAK-2
(1:1000), anti-phospho STAT3 (1:1000) or anti-phospho pan-PKC
antibody (1:4000). The membrane was incubated with a peroxidase-
labeled goat anti-rabbit or anti-mouse immunoglobulin (Dako)
before detection with enhanced chemiluminescence (Amersham
Pharmacia Biotech, Arlington, IL, USA). The immunoblot images
were quantitated using ImageQuant software (Molecular Dynamic,
Sunnyvale, CA, USA). Densitometry results were reported as % of
control after normalization with the average arbitrary integrated
values of the actin signal.
Measurement of TGF-b or leptin in culture supernatant
The concentration of TGF-b or leptin in supernatant was measured
by ELISA (R&D System) with a detection limit of 32 or 20 pg/ml
and a coefficient of variation of 8.5 or 7.6%, respectively.
Statistical analysis
All data were expressed as means7s.d. Intergroup differences
between two variables were assessed by the unpaired t-test. The data
from more than two study groups were analyzed using multivariate
analysis of variance followed by Bonferroni correction. All ‘P’-values
quoted are two-tailed and the significance is defined as Po0.005.
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